A leaked draft of an alleged White House executive order on drug prices calls for value-based contracts, lower Medicare beneficiary out-of-pocket costs, drug rebate reforms, restricted hospital drug discounts, faster FDA approvals and higher prices in other countries. Those proposals are considered drug-industry friendly, and would hurt hospitals and plans, but drug lobbyists believe the executive order will end up being worse for the drug industry by the time it is released. White House spokesperson Ninio Fetalvo said the draft...